Home Cart 0 Sign in  

[ CAS No. 57772-57-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 57772-57-3
Chemical Structure| 57772-57-3
Structure of 57772-57-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 57772-57-3 ]

Related Doc. of [ 57772-57-3 ]

Alternatived Products of [ 57772-57-3 ]

Product Details of [ 57772-57-3 ]

CAS No. :57772-57-3 MDL No. :MFCD00239284
Formula : C7H5IO3 Boiling Point : -
Linear Structure Formula :- InChI Key :QTYOSOIAZLKAGU-UHFFFAOYSA-N
M.W : 264.02 Pubchem ID :1238003
Synonyms :

Calculated chemistry of [ 57772-57-3 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 2.0
Molar Refractivity : 48.14
TPSA : 57.53 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.68 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.1
Log Po/w (XLOGP3) : 1.74
Log Po/w (WLOGP) : 1.7
Log Po/w (MLOGP) : 1.91
Log Po/w (SILICOS-IT) : 1.71
Consensus Log Po/w : 1.63

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -2.91
Solubility : 0.324 mg/ml ; 0.00123 mol/l
Class : Soluble
Log S (Ali) : -2.56
Solubility : 0.719 mg/ml ; 0.00272 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.15
Solubility : 1.88 mg/ml ; 0.00711 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 1.72

Safety of [ 57772-57-3 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 57772-57-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 57772-57-3 ]
  • Downstream synthetic route of [ 57772-57-3 ]

[ 57772-57-3 ] Synthesis Path-Upstream   1~14

  • 1
  • [ 57772-57-3 ]
  • [ 73502-04-2 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 5, p. 1428 - 1433
  • 2
  • [ 394-31-0 ]
  • [ 57772-57-3 ]
YieldReaction ConditionsOperation in experiment
88%
Stage #1: With hydrogenchloride; sodium nitrite In water at 0℃; for 0.5 h;
Stage #2: With potassium iodide In water at 90℃; for 0.5 h;
The solution of 5-hydroxyanthoranic acid (1.99 g, 1.33 mmol) in water (20 ml) was added to HCl (10 ml) and NaNO2 (1.08 g, 45.6 mmol). The mixture was stirred at 0 °C for 30 min and then mixture was added KI (3.24 g, 19.5 mmol) and water (5 ml). The result mixture was stirred at 90 °C for 30 min. The mixture extracted with ethyl acetate, and organic layer was washed with H2O, dried (MgSO4) and evaporated. The product was isolated by silica gel column chromatography to give the title compound 2 (2.15 g, 88percent) as brown solid mp=180 °C; IR (KBr) νmax=3293, 1700, 1666, 1583, 1477, 1427, 1307, 1265, 1241, 1222, 1018, 933, 877, 827, 782 cm-1; 1H NMR (500 MHz, DMSO): δ=6.69 (1H, d, J=8.5 Hz), 7.13 (1H, s), 7.71 (1H, d, J=8.5 Hz), 9.9 (1H, s), 13C NMR (DMSO) δ=80.5, 117.8, 120.6, 137.9, 141.7, 157.8, 168.3. HRMS (APCI): m/z [M+H]+ calcd for C7H5IO3: 264.9361; found: 264.9377.
37%
Stage #1: With sulfuric acid In water at 4℃;
Stage #2: With potassium iodide; sodium nitrite In water at 4 - 90℃;
Synthesis of 5-Hydroxy-2-iodo-benzoic acid (2).; Suspension of 2-amino-5- hydroxybenzoic acid (5.0 g, 32.7 mmol) in deionized water (100 mL) was mixed with 60 mL of concentrated sulfuric acid, which was added dropwise, resulting in a clear solution, which was held at 4 0C overnight, yielding suspension of white crystals. The suspension, while still cold, was mixed with 20 mL of an aqueous solution of sodium nitrite (2.4 g, 34.8 mmol). The resulting yellow-orange solution was mixed with 20 mL of an aqueous solution of potassium iodide (7.4 g, 44.6 mmol), which was added dropwise. The resulting mixture, dark-brown in color, was kept at 90 0C for 1 h and then was kept at 4 0C overnight affording dark red to brown crystals, which were filtered off and redissolved in 100 mL of deionized boiling water. Activated charcoal (7 g) was added to the hot solution, which was held at 90 0C for 1 h. The slurry, while hot, was filtered off using filter paper (retention, 10 μm) and the supernatant was kept at 40C resulting in faintly orange crystals, which were filtered off and dried in a desiccator at r.t. C7H5IO3, found (calc): C, 31.51 (31.84); H, 2.14 (1.91); I, 47.31 (48.07). 1H NMR (400 MHz, DMSO-d6): δ 5.1 (s, IH, OH), 6.81, 7.38, 7.71 (H3, H5, H2, IH each, in aromatic ring), 11 (s, 1 H, COOH). Yield, 3.2 g (37 molpercent).
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 5, p. 1428 - 1433
[2] Angewandte Chemie - International Edition, 2001, vol. 40, # 23, p. 4393 - 4394
[3] Tetrahedron, 2016, vol. 72, # 47, p. 7633 - 7637
[4] Chemistry - An Asian Journal, 2016, vol. 11, # 22, p. 3267 - 3274
[5] Chemistry--A European Journal, 2014, vol. 20, # 36, p. 11336 - 11339,4
[6] Bioorganic and medicinal chemistry letters, 2002, vol. 12, # 15, p. 2047 - 2049
[7] Patent: WO2009/55128, 2009, A2, . Location in patent: Page/Page column 40
[8] Journal of the American Chemical Society, 1984, vol. 106, # 9, p. 2651 - 2655
[9] Tetrahedron, 2000, vol. 56, # 27, p. 4777 - 4792
[10] Angewandte Chemie - International Edition, 2001, vol. 40, # 23, p. 4395 - 4397
[11] Journal of the American Chemical Society, [12] Journal of the American Chemical Society, 2009, vol. 131, p. 251 - 262
[13] Patent: WO2011/32277, 2011, A1, . Location in patent: Page/Page column 87
[14] Tetrahedron, 2012, vol. 68, # 39, p. 8358 - 8366
[15] Journal of Medicinal Chemistry, 2012, vol. 55, # 17, p. 7360 - 7377
[16] Organic and Biomolecular Chemistry, 2017, vol. 15, # 11, p. 2403 - 2410
  • 3
  • [ 99-06-9 ]
  • [ 57772-57-3 ]
Reference: [1] Journal of the American Chemical Society, 1917, vol. 39, p. 452
[2] Tetrahedron, 2012, vol. 68, # 39, p. 8358 - 8366
  • 4
  • [ 107946-58-7 ]
  • [ 57772-57-3 ]
Reference: [1] Journal of the American Chemical Society, 1984, vol. 106, # 9, p. 2651 - 2655
  • 5
  • [ 154607-00-8 ]
  • [ 57772-57-3 ]
Reference: [1] Synlett, 2016, vol. 27, # 12, p. 1794 - 1797
  • 6
  • [ 50765-11-2 ]
  • [ 57772-57-3 ]
Reference: [1] Journal of the Chemical Society, 1937, p. 76
  • 7
  • [ 100-83-4 ]
  • [ 57772-57-3 ]
Reference: [1] Journal of the Chemical Society, 1937, p. 76
  • 8
  • [ 107946-58-7 ]
  • [ 57772-57-3 ]
Reference: [1] Tetrahedron, 2012, vol. 68, # 39, p. 8358 - 8366
  • 9
  • [ 7664-41-7 ]
  • [ 7553-56-2 ]
  • [ 99-06-9 ]
  • [ 57772-57-3 ]
Reference: [1] Journal of the American Chemical Society, 1917, vol. 39, p. 452
  • 10
  • [ 10034-85-2 ]
  • [ 57772-57-3 ]
Reference: [1] Justus Liebigs Annalen der Chemie, 1891, vol. 263, p. 234
  • 11
  • [ 57772-57-3 ]
  • [ 74-88-4 ]
  • [ 857599-37-2 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 5, p. 1428 - 1433
[2] Chemistry - An Asian Journal, 2016, vol. 11, # 22, p. 3267 - 3274
  • 12
  • [ 57772-57-3 ]
  • [ 77-78-1 ]
  • [ 857599-37-2 ]
Reference: [1] Chemistry--A European Journal, 2014, vol. 20, # 36, p. 11336 - 11339,4
[2] Journal of the American Chemical Society, [3] Journal of the American Chemical Society, 2009, vol. 131, p. 251 - 262
[4] Journal of Medicinal Chemistry, 2012, vol. 55, # 17, p. 7360 - 7377
  • 13
  • [ 186581-53-3 ]
  • [ 57772-57-3 ]
  • [ 857599-37-2 ]
Reference: [1] Journal of the American Chemical Society, 1948, vol. 70, p. 2314,2317
  • 14
  • [ 57772-57-3 ]
  • [ 54413-93-3 ]
Reference: [1] Journal of Medicinal Chemistry, 2012, vol. 55, # 17, p. 7360 - 7377
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 57772-57-3 ]

Aryls

Chemical Structure| 54413-93-3

[ 54413-93-3 ]

2-Iodo-5-methoxybenzoic acid

Similarity: 0.93

Chemical Structure| 88-67-5

[ 88-67-5 ]

2-Iodobenzoic acid

Similarity: 0.91

Chemical Structure| 52548-14-8

[ 52548-14-8 ]

2-Iodo-5-methylbenzoic acid

Similarity: 0.91

Chemical Structure| 1829-21-6

[ 1829-21-6 ]

2-Iodo-4-methylbenzoic acid

Similarity: 0.89

Chemical Structure| 610-97-9

[ 610-97-9 ]

Methyl 2-iodobenzoate

Similarity: 0.86

Carboxylic Acids

Chemical Structure| 54413-93-3

[ 54413-93-3 ]

2-Iodo-5-methoxybenzoic acid

Similarity: 0.93

Chemical Structure| 88-67-5

[ 88-67-5 ]

2-Iodobenzoic acid

Similarity: 0.91

Chemical Structure| 52548-14-8

[ 52548-14-8 ]

2-Iodo-5-methylbenzoic acid

Similarity: 0.91

Chemical Structure| 1829-21-6

[ 1829-21-6 ]

2-Iodo-4-methylbenzoic acid

Similarity: 0.89

Chemical Structure| 129833-31-4

[ 129833-31-4 ]

2-Iodo-3,4-dimethylbenzoic acid

Similarity: 0.85